| V930 DNA-EP | V930 DNA-EP | Total |
---|---|---|---|
 | 0.25 mg | 2.5 mg |  |
 | n (%) | n (%) | n (%) |
Total number of patients | 6 | 22 | 28 |
Worst pain experienced by patient: | Â | Â | Â |
entire study b | 1 (17) | 3 (14) | 4 (14) |
 0 | 2 (33) | 4 (18) | 6 (21) |
 1 | 2 (33) | 6 (27 | 8 (29) |
 2 | 1 (17) | 5 (23) | 6 (21) |
 3 | 0 | 2 (9) | 2 (7) |
 4 | 0 | 2 (9) | 2 (7) |
 5 |  |  |  |
Worst pain experienced by patient: day 1 b | Â | Â | Â |
 0 | 1 (17) | 6 (27) | 7 (25) |
 1 | 3 (50) | 5 (23) | 8 (29) |
 2 | 2 (33) | 5 (23) | 7 (25) |
 3 | 0 | 4 (18) | 4 (14) |
 4 | 0 | 1 (5) | 1 (4) |
 5 | 0 | 1 (5) | 1 (4) |
Worst pain experienced by patient: day 15 b | Â | Â | Â |
 0 | 3 (50) | 4 (18) | 7 (25) |
 1 | 3 (50) | 6 (27) | 9 (32) |
 2 | 0 | 6 (27) | 6 (21) |
 3 | 0 | 3 (14) | 3 (11) |
 4 | 0 | 2 (9) | 2 (7) |
 5 | 0 | 1 (5) | 1 (4) |
Worst pain experienced by patient: day 29 b | Â | Â | Â |
 0 | 3 (50) | 5 (23) | 8 (29) |
 1 | 1 (17) | 5 (23) | 6 (21) |
 2 | 1 (17) | 7 (32) | 8 (29) |
 3 | 1 (17) | 2 (9) | 3 (11) |
 4 | 0 | 1 (5) | 1 (4) |
 5 | 0 | 2 (9) | 2 (7) |
Worst pain experienced by patient: day 43 b | Â | Â | Â |
 0 | 2 (33) | 4 (18) | 6 (21) |
 1 | 2 (33) | 8 (36) | 10 (36) |
 2 | 2 (33) | 5 (23) | 7 (25) |
 3 | 0 | 2 (9) | 2 (7) |
 4 | 0 | 1 (5) | 1 (4) |
 5 | 0 | 2 (9) | 2 (7) |
Worst pain experienced by patient: day 57 b | Â | Â | Â |
 0 | 2 (33) | 5 (23) | 7 (25) |
 1 | 2 (33) | 8 (36) | 10 (36) |
 2 | 1 (17) | 2 (9) | 3 (11) |
 3 | 1 (17) | 3 (14) | 4 (14) |
 4 | 0 | 1 (5) | 1 (4) |
 5 | 0 | 2 (9) | 2 (7) |